Skip to main content
. 2019 Mar 27;6(2):245–254. doi: 10.1007/s40744-019-0152-8

Fig. 1.

Fig. 1

Study schema. ISP injection site pain, SC subcutaneous, sequence AB treatment A followed by sequence B, sequence BA sequence B followed by sequence A, VAS visual analog scale